Effects of Ketamine on Human Bladders and Its Possible Mechanisms
NCT00957333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44
Last updated 2016-01-14
Summary
This study is aimed to evaluate the relationship between ketamine abused and bladder dysfunction and its possible mechanisms.
Conditions
- Cystitis
Interventions
- OTHER
-
ketamine
Sponsors & Collaborators
-
Taipei Medical University WanFang Hospital
lead OTHER
Principal Investigators
-
Ruei-Ming Chen, PhD · Taipei Medical University-Wan Fang Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2009-12-31
- Completion
- 2011-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Utilization of PTNS During Office-Based Cystoscopy
NCT04440579 ·Status: COMPLETED ·Phase: NA
-
Clinical Assessment of Urinary Antiseptics Methenamine and Methylthioninium in Recurrent Cystitis
NCT03379389 ·Status: COMPLETED ·Phase: PHASE4
-
Intranasal Fentanyl as an Analgesic for Cystoscopic Procedures
NCT01708122 ·Status: COMPLETED ·Phase: PHASE4
-
The Urinary Microbiome in Patients Receiving Intradetrusor Botox Injections
NCT04479709 ·Status: COMPLETED
-
Autonomic Response During Cystodistension in Patients Suspected of Having Interstitial Cystitis
NCT01301365 ·Status: UNKNOWN
-
Antibiotic Prophylaxis for Clean Intermittent Catheterisation
NCT02145338 ·Status: COMPLETED ·Phase: PHASE4
-
Perioperative Safety of Bladder Hydrodistension in Patients on Antithrombotic Therapy
NCT05221944 ·Status: UNKNOWN
-
Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms.
NCT01884753 ·Status: COMPLETED
-
Heating Pad for in Office Cystoscopy and Urodynamic Testing
NCT05981794 ·Status: WITHDRAWN ·Phase: NA
-
A Follow-net Investigation of a Randomised Study of Cystoscopy and Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding
NCT02297178 ·Status: WITHDRAWN
-
Using Oral Valacyclovir to Treat Patients With Refractory IC/BPS
NCT05094414 ·Status: UNKNOWN ·Phase: PHASE1
-
Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis
NCT05912946 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis
NCT04610359 ·Status: UNKNOWN ·Phase: PHASE1
-
Corticosteroids for Children With Febrile Urinary Tract Infections
NCT01391793 ·Status: COMPLETED ·Phase: PHASE3
-
Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC
NCT05223244 ·Status: COMPLETED ·Phase: PHASE4
-
Emotional Urinary Tract Infection
NCT07191041 ·Status: NOT_YET_RECRUITING
-
Health-related QoF Between OAB-wet and OAB-dry Women
NCT03806855 ·Status: COMPLETED
-
Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets in Acute Bacterial Cystitis.
NCT00305071 ·Status: UNKNOWN ·Phase: PHASE2
-
Red Clover Isoflavones in Postmenopausal Women With Urge Urinary Incontinence and Overactive Bladder
NCT05013593 ·Status: COMPLETED ·Phase: NA
-
Genetic and Histopathologic Characteristics of Interstitial Cystitis
NCT03523559 ·Status: COMPLETED
-
DMSO Efficacy in IC/PBS Patients During and After Treatment
NCT01074567 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (Pilot Study)
NCT02331472 ·Status: COMPLETED
-
Antibiotic Prophylaxis for Neurogenic Bladder Botox
NCT04791579 ·Status: RECRUITING ·Phase: PHASE2
-
Observational Study With Mode of Action-Analysis of Cystorenal Cranberry Extract in Patients With Recurrent Urinary Tract Infections
NCT03019874 ·Status: COMPLETED
-
Urinary Cytokines in Patients With Overactive Bladder (OAB)
NCT00868621 ·Status: COMPLETED